Mutational Analysis of the H-ras Oncogene in Spontaneous C57BL/6 × C3H/He Mouse Liver Tumors and Tumors Induced with Genotoxic and Nongenotoxic Hepatocarcinogens

Cancer Research

Volumn 50, Issue 13, 1990, Pages 4014-4019

  Fox, Tony R ^a,b   Schumann, Alan M ^a   Watanabe, Philip G ^a   Yano, Barry L ^a   Maher, Veronica M ^b   McCormick, J Justin ^b  

^a DOW CHEMICAL COMPANY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIDINE; CHLOROFORM; CIPROFIBRATE; PHENOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; GENE MUTATION; GENETIC ENGINEERING; LIVER CARCINOGENESIS; LIVER TUMOR; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL;

ANIMAL; BASE SEQUENCE; BENZIDINES; CHLOROFORM; CLOFIBRIC ACID; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, RAS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PHENOBARBITAL; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025330349     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chen, C. NTP technical report on the toxicology and characterization studies of dimethylmorphoenophosphoramidate in F344/N rats and B6C3Fi mice. Cas No. 597–25–1, 1984.
2. Ward, J. M., Goodman, D. G., Squire, R. A., Chu, K. C., and Lin hart, M. S. Neoplastic and nonneoplastic lesions in aging C57BL/6N × C3H/HeN) F, (B6C3F,). J. Natl. Cancer Inst., 63: 849–854, 1979.
3. Ashby, J., and Tennant, R. W. Chemical structure, Salmonella mutagenicity, and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the US NCI/NTP. Mutat. Res., 204: 17–115,1988.
4. Franks, L. M., and Feich, N. (eds.). Cellular and Molecular Biology of Cancer. New York: Oxford University Press, 1986.
5. Schulte-Hermann, R., Timmermann-Trosiemer, I., and Schuppler, J. Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res., 43: 839–844, 1983.
6. Frenkel, K., and Chrzan, K. DNA base modification by tumor promoting activated polymorphonuclear leukocytes. Carcinogenesis (Lond.), 8: 455–460, 1987.
7. Fox, T. R., Schumann, A. M., and Watanabe, P. G. Activation of a cellular proto-oncogene in spontaneous liver tumor tissue of the B6C3F| mouse. Arch. Toxicol. Suppl., 10:217–227, 1987.
8. Reynolds, S. H., Stowers, S. J., Maronpot, R. R., Anderson, M. W., and Aaronson, S. A. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F, mouse. Proc. Natl. Acad. Sci. USA, 86: 33–37, 1986.
9. Wiseman, R. W., Stowers, S. J., Miller, E. C., Anderson, M. W., and Miller, J. A. Activating mutations of the C-Ha-ras proto-oncogene in chemically induced hepatomas of the male B6C3Fi mouse. Proc. Natl. Acad. Sci. USA, 55:5825–5829, 1986.
10. Reynolds, S. H., Stowers, S. J., Patterson, R. M., Maronpot, R. R., Aaronson, S. A., and Anderson, M. W. Activated oncogenes in B6C3F| mouse liver tumors: implications for risk assessment. Science (Wash. DC), 237: 1309–1316, 1987.
11. Mullis, K., and Faloona, F. Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods Enzymol., 155: 335–350, 1987.
12. Yang, J-L., Maher, V. M., and McCormick, J. J. Amplification and direct nucleotide sequencing of cDNA from the lysate of low numbers of diploid human cells. Gene, 83(2): 347–354, 1989.
13. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463–5467, 1977.
14. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779–827, 1987.
15. Fasano, O., Taparowsky, E., Fiddes, J., Wigler, M., and Goldfarb, M. Sequence and structure of the coding region of the human H-ros-1 gene from T24 bladder carcinoma cells. J. Mol. Appl. Gent., 2: 173–180, 1983.
16. Reddy, E. P., Lysman, D., Andersen, P. R., Tronick, S. R., and Aarnson, S. A. Nucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene. J. Virol., 53:984–987, 1985.
17. Strauss, B., Rabkin, F., Sagher, D., and Moore, P. The role of DNA polymerase in base substitution mutagenesis on noninstructional templates. Biochimie (Paris), 674: 829–838, 1982.
18. Josephy, P. D. Benzidine: mechanism of oxidative activation and mutagenesis. Fed. Proc., 45: 2465–2470, 1986.
19. Norman, D., Abuaf, P., Hingerty, B. F., Lide, D., Grunberger, D., Broyde, S., and Patel, D. J. NMR and conformational characterization of the N-(deoxyguanosine-8-yl)aminofluorine adduct-((AF)G] opposite adenosine in DNA; (AFG[syn] - A[anti] pair formation and its' pH dependence. Biochemistry, 28(18): 7462–7476, 1989.
20. Stowers, S. J., Wiseman, R. W., Ward, J. M., Miller, E. C., Miller, J. A., Anderson, M. W., and Eva, A. Detection of activated proto-oncogenes in N-nitrosodiethnylamine induced liver tumors: a comparison between B6C3F, mice and Fischer 344 rats. Carcinogenesis (Lond.), 9: 271–276, 1988.
21. Balmain, A., Ramsden, M., Bowden, G. T., and Smith, J. Activation of the mouse cellular Harvey-ro? gene in chemically induced benign skin papillomas. Nature (Lond.), 307:658–660, 1984.
22. Peraino, C., Fay, R. J. M., Staflfeldt, E., and Christopher, J. P. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyl-trichloroethylane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res., 35: 2884–2890, 1975.
23. Reitz, R. H., Fox, T. R., and Quast, J. F. Mechanistic considerations for carcinogenic risk estimation: chloroform. Environ. Health Perspect., 46: 163–168, 1982.
24. Kakunaga, T. The role of cell division in the malignant transformation of mouse cells treated with 3-methylcholanthrene. Cancer Res., 35:1637–1642, 1975.
25. Mironescu, S., and Love, R. DNA synthesis and transformation induced in density-inhibited cultures of hamster embryo cells by the carcinogen benzo(fl)pyrene. Cancer Res., 34: 2562–2570, 1974.
26. Reddy, J. K., and Lalwani, N. D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12:1–58, 1983.
27. Cattley, R. C., and Popp, J. A. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res., 49: 3246–3251, 1989.